Yujiro Hata

Mr. Yujiro S.
Hata is an Independent Director at Enanta Pharmaceuticals, Inc., a Chairman, President & Chief Executive Officer at IDEAYA Biosciences, Inc., a Director-Moores Cancer Center at University of California San Diego and a Venture Partner at The Column Group LLC.
He is on the Board of Directors at Hexagon Bio, Inc., Enanta Pharmaceuticals, Inc. and Experimed Bioscience, Inc. Mr. Hata was previously employed as an Independent Director by Xencor, Inc., a Chief Operating Officer by Flexus Biosciences, Inc., a Chief Operating Officer by FLX Bio, Inc., a VP-Corporate Development & Strategy by Onyx Pharmaceuticals, Inc., a Chief Business Officer & SVP-Business Development by Enanta Pharmaceuticals, Inc., a Head-Business Development by ImClone LLC, and a Principal by McKinsey & Co., Inc. He also served on the board at Expansion Therapeutics, Inc. and Oscient Pharmaceuticals Corp.
He received his undergraduate degree from the University of Oxford, an undergraduate degree from The Colorado College and an MBA from The Wharton School of the University of Pennsylvania.